Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects.

Vollenberg, Richard; Lorentzen, Eva Ulla; Kühn, Joachim; Nowacki, Tobias Max; Meier, Jörn Arne; Trebicka, Jonel; Tepasse, Phil-Robin

Vollenberg, Richard; Lorentzen, Eva Ulla; Kühn, Joachim; Nowacki, Tobias Max; Meier, Jörn Arne; Trebicka, Jonel; Tepasse, Phil-Robin.

Afiliación

Vollenberg R; Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clincial Infectiology, University Hospital Muenster, 48149 Muenster, Germany.
Lorentzen EU; Institute of Virology, University Hospital Muenster, 48149 Muenster, Germany.
Kühn J; Institute of Virology, University Hospital Muenster, 48149 Muenster, Germany.
Nowacki TM; Department of Medicine, Gastroenterology, Marienhospital Steinfurt, 48565 Steinfurt, Germany.
Meier JA; Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clincial Infectiology, University Hospital Muenster, 48149 Muenster, Germany.
Trebicka J; Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clincial Infectiology, University Hospital Muenster, 48149 Muenster, Germany.
Tepasse PR; Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clincial Infectiology, University Hospital Muenster, 48149 Muenster, Germany.

Vaccines (Basel) ; 11(9)2023 Aug 24.

Article en En | MEDLINE | ID: mdl-37766088

Palabras clave

COVID-19; IBD patients; SARS-CoV-2; humoral immune response; seroconversion; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google